The record set an inspector expects for a vial lot

An auditor asks for the certificate of analysis for lot 22G-0417, the 2 mL clear vial used in the assay run from March. You have the COA. You do not have the incoming inspection record that shows you checked it, the drawing revision that was current on the date of manufacture, or the retention sample that would let you re-verify the septum thickness. That is three findings from one request, and it is the most common pattern in vial audit documentation and record retention failures: the document exists somewhere, but the record set that connects it to the method, the lot, and the date does not.

This article covers what an inspector actually asks to see for vials, how long each record must be kept, and the three gaps that recur across audits. It does not cover revalidation triggers or traceability chain design, which are separate problems with separate answers.

Vials are components, not excipients, and inspectors treat them accordingly. The record set has four layers, and a finding appears when any layer is missing or cannot be tied to the others by lot number and date.

Layer 1: the specification and its revision history

The controlled specification is the anchor. For a 2 mL HPLC vial it typically defines:

• Dimensions: 12 × 32 mm body, 11 mm crimp or 9 mm screw thread, per the dimensional conventions in the applicable GPI/ISO glass finish standards.
• Glass: Type I borosilicate, USP <660> hydrolytic resistance class.
• Septum: silicone core with PTFE facing, thickness and durometer specified, with a stated puncture count for the intended use.
• Closure: cap material, liner, and the torque or crimp dimension the method assumes.
• Performance attributes: extractables screen, dimensional tolerances, visual defect AQL.

The inspector wants the revision that was in force on the date the lot was manufactured, not the current one. If the specification changed between manufacture and audit, you need to show which revision governed and what the change was. A specification file that only shows the current version is a gap, because it cannot prove what the lot was made against.

Layer 2: the supplier’s certificate of analysis and conformance

The COA is the supplier’s claim. It is not your evidence that the lot meets your specification. Inspectors know the difference and will ask for both. The COA should carry the lot number, the specification revision it was tested against, the test methods, the results, and the date of manufacture. A COA that lists results without methods is weak but usually accepted if your incoming inspection covers the critical attributes.

If the vial is used in a regulated method, the COA should also reference the functional testing the method depends on. For a headspace vial, that includes the crimp dimension and the septum performance under the method’s temperature program. For a GC vial, it includes the septa puncture specification and the inertness screen relevant to the analytes.

Layer 3: your incoming inspection record

This is where most findings land. The inspection record must show what you checked, against what acceptance criteria, on what date, by whom, and with what result. For vials, a defensible incoming inspection typically covers:

• Dimensional check on a sample: body diameter, height, and closure fit.
• Visual defect check against an AQL plan (for example, ANSI/ASQ Z1.4, general inspection level II, AQL 1.0 for critical defects).
• Functional check where the method is sensitive: septum puncture, crimp or torque verification, or a blank injection screen.
• Lot number and quantity received, tied to the receiving record.

The record needs the acceptance criteria stated, not just a pass/fail mark. “Passed visual” is not a record. “Passed visual, AQL 1.0, n=125, 0 critical defects, 2 minor” is.

Layer 4: the use record

The use record ties the lot to the method and the run. At minimum: which lot was used in which analytical run, on what date, and under which method revision. If a run is later questioned, this is the record that lets you pull the right retention samples and re-test. Without it, you can prove the lot met specification but not that it was the lot in the suspect run.

Retention periods: what to keep and for how long

Retention periods for vial records follow the same rules as the records they support. The vial record is not kept on its own clock; it is kept as long as the batch or method it supports requires.

The baseline rules

Under 21 CFR 211.180, records associated with a batch must be retained for at least one year after the expiry date of the batch, or three years after distribution, whichever is longer. For OTC drugs without an expiry date, the rule is three years after distribution. For records tied to a method rather than a batch, the retention follows the method’s life plus the period the data must remain available for review.

For laboratories operating under ISO/IEC 17025, records must be retained for a period defined by the laboratory, and that period must be documented. A common defensible choice is five years for raw data and the life of the method plus five years for method-related records. The key point is that the period is written down and followed, not that it matches a specific number.

Environmental and waste methods under U.S. EPA SW-846 carry their own record requirements, and vial records used in those methods should be retained with the method records for the period the program specifies. If the vial is used across GMP and environmental work, retain to the longer of the applicable periods.

What most sites get wrong about retention

Retention is usually treated as a storage problem. It is a retrieval problem. An inspector who asks for a record from three years ago and waits twenty minutes has found a gap, even if the record exists. The test is whether you can retrieve the lot-specific record set, complete, within the time the inspector is willing to wait.

Two practical rules help:

• Retain the record set as a set, indexed by lot number, not as separate files in separate systems.
• Keep the retention sample (a sealed unit or two from each lot) for the same period as the records, stored under conditions that preserve the septum and closure.

A retention sample of a vial from a lot used three years ago is worth more than any document when the question is whether the septum was the specified durometer.

The three gaps that show up most often

Across audits of vial documentation, three failures recur. They are not exotic. They are structural, and they are fixable before the visit.

Gap 1: the specification revision cannot be tied to the lot

Symptom: the auditor asks which revision of the vial specification governed lot 22G-0417. The file shows revision C, effective January. The lot was manufactured in November of the previous year under revision B. No one can produce revision B, or the change record that shows what changed between B and C.

Useful measurement: count the lots in the retention period that were manufactured before the most recent specification change. If that number is greater than zero and the superseded revision is not retrievable, the gap is confirmed.

Corrective action: maintain a revision archive with effective dates, and index it so that any lot number maps to the revision in force on its manufacture date. Where the change was material (glass source, septum compound, closure geometry), the change record should state what was evaluated and the conclusion. A one-line change record is a finding waiting to happen.

Gap 2: incoming inspection records that record the result but not the method

Symptom: the inspection record shows “dimensional: pass” with a date and initials. There is no sample size, no acceptance criteria, no measurement values, and no reference to the inspection plan. The auditor cannot tell whether the check was meaningful or a rubber stamp.

Useful measurement: pull ten incoming inspection records at random and count how many state the acceptance criteria and sample size. If fewer than all ten do, the gap is systemic rather than a one-off.

Corrective action: rewrite the inspection form so that the criteria and sample size are pre-printed and the inspector records values, not verdicts. For dimensional checks, record the measured value and the tolerance. For visual checks, record the AQL plan and the defect counts by class. This is the same discipline a reagent bottle inspection needs, and the form design is reusable.

Gap 3: the use record does not connect the lot to the run

Symptom: a run is questioned six months later. You can show the lot met specification. You cannot show which lot was in the autosampler on the date of the run, because the use record lists “vials, 2 mL” without a lot number.

Useful measurement: pick a run from the retention period and try to trace it to a lot number in under five minutes. If you cannot, the gap is confirmed.

Corrective action: add the lot number to the run record or the bench sheet at the point of use. This is a one-field change with a large compliance return. Where multiple lots are open at once, the field is the only thing that separates them.

A retention and retrieval checklist with concrete thresholds

The table below is a working checklist. The thresholds are illustrative defaults; adjust them to your method and your regulator, but write the adjusted values down.

Two notes on the table. First, the retrieval target is the part most sites omit, and it is the part that decides whether the audit goes smoothly. Second, the retention sample row is not optional for vials, because the physical unit is often the only way to resolve a question about a material attribute after the fact.

Two diagnostic examples

Both examples below are hypothetical. They illustrate the measurement and the corrective action, not a specific site’s results.

Example 1: the COA that does not match the specification revision

Symptom: an auditor compares the COA for a lot against the specification and finds the COA reports septum thickness to a tolerance that does not appear in the current specification. The lot was made under an earlier revision that used a wider tolerance.

Measurement: pull the COA, the specification revision in force on the manufacture date, and the change record. Compare the tolerance on the COA to the tolerance in each revision. If the COA matches the earlier revision and the change record does not explain the tightening, the finding is that the change was not evaluated.

Corrective action: retrieve the superseded revision, document the change and its evaluation, and confirm that lots made under the earlier revision remain acceptable for their intended use. If the tightening was material to the method, the evaluation should say so and reference the supporting data.

Example 2: the retention sample that cannot answer the question

Symptom: a customer question arises about septum coring in a lot used eight months earlier. The retention sample exists, but it was stored in an uncontrolled cabinet and the septum has taken a set. It cannot be used to re-test.

Measurement: inspect the retention sample storage conditions against the conditions the specification assumes. If temperature or humidity is uncontrolled, or if the sample was stored uncapped, the sample is compromised.

Corrective action: store retention samples sealed, in the closure configuration used in the method, under controlled conditions, and record the storage location. A retention sample that cannot be re-tested is a record that exists but does not function.

Building the record set before the audit, not during it

The practical sequence is short. Map every vial lot in the retention period to four records: specification revision, COA, incoming inspection, and use. Where any link is missing, fix it now, because the auditor will find it in the order the lot numbers appear. Then test retrieval: pick three lots at random and pull the full set within the target times in the table. If you cannot, the gap is in the index, not the records.

For the technical content that supports the specification itself, the supplier’s documentation and independent resources are worth reviewing before you finalize the record set. Agilent’s chromatography consumables documentation and Thermo Fisher’s chromatography and sample handling resources are useful for confirming what a vial specification should state for a given method. Restek’s technical resources are useful for the septum and inertness attributes that the COA should report.

The decision rule is this: a vial record is compliant when a lot number resolves, within the retrieval target, to the specification revision in force at manufacture, the supplier COA, your incoming inspection with stated criteria, and the run that used it. If any of those four cannot be produced on demand, the record set is incomplete regardless of how many documents exist in the file.

References & further reading

Related resources from our lab consumables network:

• Vial at vials-filters.com
• Headspace Vial at headspacevialsupplier.com
• Gc Vial at gcvialfactory.com
• Reagent Bottle at reagentbottleforsale.com

External references and standards:

• Agilent chromatography consumables and columns
• Thermo Fisher chromatography and sample handling
• U.S. EPA SW-846 test methods for waste and materials
• Restek technical resources for chromatography